Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has informed the stock exchanges that the trading window for its securities will remain closed from July 1, 2025, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2025 (Q1 FY26). This is a standard compliance filing under SEBI's Insider Trading Regulations, 2015, and applies to designated persons, their immediate relatives, and insiders. The Board meeting date to approve the Q1 FY26 results has not yet been announced and will be communicated later. No financial figures, business updates, or material developments were disclosed in this filing.
This is a routine regulatory filing with no direct impact on shareholders or the stock price. However, it signals that the Q1 FY26 earnings announcement is likely due in the coming weeks, which investors should watch for.